Status:

COMPLETED

Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery

Lead Sponsor:

Ethicon, Inc.

Collaborating Sponsors:

Johnson & Johnson Medical, China

Conditions:

Breast Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This is a 90-day study to evaluate cosmetic outcome and Surgical Site Infection in approximately 100 patients from 6 centers in China undergoing scheduled modified radical mastectomy for breast cancer...

Detailed Description

Patients will be evaluated post-procedure on Days 3, 5, 7, 12, 30 and 90 for cosmetic outcome and surgical site infection.

Eligibility Criteria

Inclusion

  • 18 years of age or older with written informed consent
  • Scheduled for a modified radical mastectomy
  • Surgical wound classified Class I/Clean using the CDC SSI Surgical Wound Classification

Exclusion

  • Unable to give consent and unlikely to comply with study requirements and complete the 90-day follow up visit
  • Undergoing surgery for modified radical mastectomy with immediate breast reconstruction, cosmetic breast operations, reduction, expansion, insertion of prothesis, duct ectasia or infective breast disease or implant
  • Surgical wounds classified as Class II, III or IV using CDC SSI Surgical Wound Classification
  • Has inflammatory cancers or skin ulceration
  • Has known allergy or intolerance to triclosan
  • Has compromised wound healing or chronic immune deficiency, for example diabetes, prolonged steroid use, AIDS or substance abuse
  • Has serious heart and/or lung disease
  • Has skin scar history or family history
  • Has direct relationship to or involvement in this or other studies under the direction of the investigator or center
  • Received an experimental drug or device within 30 days prior to the planned start of treatment

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2009

Estimated Enrollment :

101 Patients enrolled

Trial Details

Trial ID

NCT00768222

Start Date

October 1 2008

End Date

May 1 2009

Last Update

August 31 2011

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Capital Medical Univ. affiliated Hospital

Beijing, China

2

Jilin Univ. affiliated Second Hospital

Changchun, China

3

Dalian Medical Univ. affiliated first Hospital

Dalian, China

4

First Affiliated Hospital, Sun Yat-sen Univ.

Guangzhou, China